Vβ18.1+ and V⍺2.3+ T-cell subsets are associated with house dust mite allergy in human subjects - 01/09/11
Abstract |
Background: The recognition of allergenic peptides by T cells through their T-cell receptor (TCR) represents a crucial step in the initiation of an allergen-specific immune response. In parallel to the superantigen-driven restricted expansion of Vβ subsets in autoimmune and infectious diseases, reports in animals and human subjects have shown a similar capacity of classical antigens. Objective: The study was performed to analyze the V⍺/Vβ expression in house dust mite (HDM) allergy. Methods: The TCR repertoire of 15 subjects with HDM allergy, 22 atopic subjects without HDM allergy, and 19 nonatopic individuals, members of 2 extended and 4 nuclear families, was determined. By using flow cytometry, the expression of 22 Vβ and 3 V⍺ elements was analyzed in vivo and after in vitro allergen stimulation. Results: In comparison with nonatopic and atopic individuals without HDM allergy, freshly isolated PBMCs of individuals with HDM allergy showed a significantly higher frequency of Vβ18+ and V⍺2.3+ T cells. Although members of all 3 groups had a similar lymphocyte proliferation response after in vitro stimulation with Der p 1 or Der p 1 peptide101-131, a significant expansion of Vβ18+ and V⍺2.3+ T cells in vitro occurred only in individuals with HDM allergy. Moreover, the degree of expansion correlated with the levels of allergen-specific IgE antibodies. No expansion of Vβ18+ and V⍺2.3+ was observed after mitogen stimulation with PHA, indicating allergen specificity of the response. Conclusion: Our results strongly suggest restricted TCR V⍺/Vβ gene use in HDM allergy and might be a step toward TCR-based immunotherapy. (J Allergy Clin Immunol 2002;109:517-23.)
Le texte complet de cet article est disponible en PDF.Keywords : T-cell receptors, allergy, T lymphocytes, flow cytometry
Abbreviations : HDM:, TCR:
Plan
Supported by Deutsche Forschungsgemeinschaft (DFG grant No. Re737/4-3 and 4-4). |
|
Reprint requests: Kirsten Beyer, MD, The Mount Sinai School of Medicine, Division of Pediatric Allergy and Immunology, Box-No. 1198, One Gustave L. Levy Place, New York, NY 10029-6574. |
Vol 109 - N° 3
P. 517-523 - mars 2002 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?